While other cultivated meat companies are collapsing, this one turned a profit | E2317
Summary
This episode explores why cultivated meat has struggled to become a mainstream food category, with the main bottlenecks being scale, cost, and immature product quality rather than simple lack of consumer interest. Jason Calacanis and Dr. Yuki Hanyu discuss how today’s cultivated meat products are still closer to a "slurry of cells" than a convincing steak, which makes texture and realism difficult. The conversation also highlights IntegriCulture’s different strategy: instead of betting everything on food, the company built a broader cell-agriculture platform and sold serum and ingredients into cosmetics first. That diversification helped the company survive when many better-funded peers collapsed, and even turned it profitable. The episode also covers the company’s origins in an open-source DIY cultured meat community, Japan’s more flexible regulatory environment, and the ongoing debate over whether these products should even be called "meat."
Key Takeaways
- 1Cultivated meat has not gone mainstream primarily because the industry has not solved scale and unit economics.
- 2Current cultivated meat products are still far from matching the texture and structure of real meat.
- 3IntegriCulture survived by avoiding a pure food-only strategy and monetizing adjacent applications like cosmetics.
- 4The company’s roots in an open-source DIY cultured meat movement helped shape its long-term identity.
- 5A staged market-entry strategy may be more realistic than starting with mass-market meat products.
Notable Quotes
""Right now the cell culture meat, what they say, is made in like large ... bioreactors. And it is not making steak. It's making like slurry of cells.""
""Our fund raise so far have been something like between 15 to 20 million USD, which is far less smaller compared to our industry peers in the US or like in Europe.""
""It's actually one of the reasons why a lot of our better funded peers are closing, whilst we're totally healthy. We actually turned profitable last year.""
""In 2018, in the seed round, we raised on a Japanese VCs and even the government backed VCs as well.""
Episode questions
Why hasn’t cultivated meat gone mainstream yet?
According to the guest, the biggest blockers are scaling and unit price, not necessarily consumer dislike. Without enough volume, companies cannot properly test market demand or lower costs enough to compete.
How did IntegriCulture survive when many cultivated meat startups failed?
It diversified early into cosmetics and broader cell-agriculture applications, generating revenue before food commercialization was ready. That allowed the company to become profitable instead of burning cash solely on the hardest food-use case.
What is the company’s product strategy for food?
It is starting with niche or “stunt” products like quail and other differentiated items rather than commodity chicken. The idea is to build market interest and regulatory acceptance before tackling mass-market products like chicken breast or hamburgers.
How did the open-source community react when the project became commercial?
The founder says the shift was anticipated because the project had always been structured with open-source, nonprofit, and for-profit layers. That clarity meant most community members were not surprised by commercialization.